Aventyn
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Aventyn sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Aventyn: 6 sponsored US clinical trials, 3 recruiting.
Aventyn sponsors 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Acute MI, with 2 trials.
Upper-quartile sponsor footprint
Aventyn sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
NCT07403669
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
NCT04905160
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
NCT04678193
Remote Monitoring of Chronic Illness Patients With a IHAP Home Wireless Hub and Vitals Measurements
NCT06330714
Assess Measurements of Wireless Cardiac Output Device
NCT02252757
Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices
NCT01430936
Therapeutic Areas
What is open in the Aventyn pipeline
3 recruiting of 6 indexed (50% open); 3 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Acute MI (2 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Aventyn: open-pipeline peers nationwide
Peers matched on 6 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Aventyn sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
Related
What to do with this Aventyn page
6 registered trials is a research-attention snapshot, not an endorsement of Aventyn or any single study.
- 3 of Aventyn's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Acute MI is the condition Aventyn studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute MI trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Aventyn pipeline card: 6 registered trials from official public datasets.Report a data error.